Edition:
United Kingdom

People: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

128.96USD
4:18pm BST
Change (% chg)

$-2.31 (-1.76%)
Prev Close
$131.27
Open
$131.07
Day's High
$131.22
Day's Low
$128.80
Volume
675,964
Avg. Vol
2,079,242
52-wk High
$148.97
52-wk Low
$122.00

Wolk, Joseph 

Mr. Joseph J. Wolk is Chief Financial Officer, Executive Vice President of the Company. He was previously Vice President, Group Finance for the Pharmaceuticals Group of Johnson & Johnson, where he provided finance leadership, supporting Worldwide Chairman, Pharmaceuticals Joaquin Duato, and Chief Scientific OfficerPaul Stoffels, as a member of the Pharmaceuticals Group Operating Committee. Prior to that role, he held other finance leadership positions at Johnson & Johnson as Vice President of Finance for the Medical Devices Global Supply Chain, and as Chief Financial Officer of the North America Pharmaceuticals Group, responsible for Centocor Ortho Biotech Inc. as well as U.S. Pricing Strategy and Compliance. Wolk joined Johnson & Johnson in 1998 as a Finance Manager in the Ortho-McNeil Pharmaceutical organization. Prior to joining Johnson & Johnson, Wolk held multiple positions of increasing responsibility at Ametek, Inc. He holds a Bachelor of Science degree in Finance from St. Joseph's University, where he currently serves on the Haub School of Business Board of Visitors, and he also holds a Juris Doctor degree from Temple University School of Law and is a Certified Public Accountant.

Basic Compensation

Total Annual Compensation, USD 1,347,270
Restricted Stock Award, USD 670,085
Long-Term Incentive Plans, USD --
All Other, USD 690,833
Fiscal Year Total, USD 2,708,190

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

20,097,600

Paulus Stoffels

10,591,800

Joaquin Duato

9,283,960

Joseph Wolk

2,708,190

Peter Fasolo

3,621,280

Michael Ullmann

5,336,150
As Of  31 Dec 2018